Which Raises The Question: How Quicklyreallycould Canada Vaccinate Everyone
First, the details: Last Friday, Prime Minister Justin Trudeau announced that, instead of receiving six million doses of vaccine by March 31, Canada would be getting eight million doses, including another 1.5 million from Pfizer and 500,000 of the recently approved AstraZeneca vaccine.
At the same press conference, Anita Anand, the public services and procurement minister, promised, Canada is on track to receive at least 36.5 million doses of vaccines by the end of June, and a cumulative total of 117.9 million doses of vaccines by the end of September from the four currently approved suppliers.
With 3.5 million doses arriving in March alone, provinces are now gearing up to handle the next phase of the national immunization campaign: mass vaccinations.
For instance, Manitoba has set itself a target of administering 20,000 doses a day by April 1, assuming vaccine supply is not an issue. Alberta Health Minister Tyler Shandro has talked of 180,000 doses a week while Premier Jason Kenney has mused about more than 200,000 doses a week by the end of March.
In Toronto, Matthew Pegg, the fire chief in charge of the citys emergency response to the pandemic, estimates that 1,400 staff will be needed to operate the citys nine mass vaccination clinics, if they are open nine hours a day, seven days a week. Those clinics are expected to vaccinate 120,000 residents a week, with the citys entire effort ramping up to 975,000 doses a month, Pegg told the Toronto Star.
Where Can I Get A Covid
All adults in the U.S. are eligible to receive a COVID-19 vaccine, and children 6 months years and older are able to receive the Pfizer vaccine. Visit Vaccines.gov to find out where vaccines are in stock near you and schedule an appointment.
You can also text your ZIP code to 438 829 to receive contact information for vaccine providers in your area.
Illustrated guide: What to expect before and after getting a COVID-19 vaccine
Populations used for U.S. state, District of Columbia and Puerto Rico calculations are from the U.S. Census Bureau’s 2019 state population estimates. Populations used for other territory and associated island state calculations are from the World Bank.
The percent of people vaccinated in each state, territory or county is calculated by dividing the number of residents of that state, territory or county who have been vaccinated by the population of that state, territory or county.
Because of reporting delays and other factors, the CDC data above may differ from that of states’ and territories’ own reports and dashboards. For more information, see the footnotes on the CDC’s website. To see the CDC’s log of changes and corrections to the data, check the historical updates.
Contributing: Mitchell Thorson, Mike Stucka and Shawn Sullivan
From Feb. 22 to 25, a footnote incorrectly described the measure used to calculate the percent of people vaccinated in each state or territory. We have corrected the error.
Has The Rollout Been Even Across All Areas
Across the country, there continues to be some variation in the vaccine programme.
Scotland has vaccinated 93% of those aged 12 and over with at least one dose, while England and Wales have hit 92% and Northern Ireland 89%.
Second doses are also being rolled out, with all nations reaching more than 80% of over-12s so far.
Across the English regions, the South West has vaccinated 87% of the same age group with at least one dose, while London has reached 70%.
When looking at boosters, the South West has reached 68% of people aged 12 and over, while for London the figure is 46%.
There have also been disparities between ethnic groups and poorer and wealthier areas.
Analysis of NHS records by the OpenSAFELY group – a collaboration between Oxford University and the London School of Hygiene and Tropical Medicine – shows that black people were the least likely to have received a booster vaccine.
The study was based on more than 20 million patient records in England and covers people not living in care homes. Areas of London are under-represented in the data.
In addition, booster take-up in poorer areas is lower than in more affluent areas.
You May Like: How Does The Gardasil Vaccine Work
The Body’s Natural Response
A pathogen is a bacterium, virus, parasite or fungus that can cause disease within the body. Each pathogen is made up of several subparts, usually unique to that specific pathogen and the disease it causes. The subpart of a pathogen that causes theformation of antibodies is called an antigen. The antibodies produced in response to the pathogens antigen are an important part of the immune system. You can consider antibodies as the soldiers in your bodys defense system. Eachantibody, or soldier, in our system is trained to recognize one specific antigen. We have thousands of different antibodies in our bodies. When the human body is exposed to an antigen for the first time, it takes time for the immune system torespond and produce antibodies specific to that antigen.
In the meantime, the person is susceptible to becoming ill.
This means that if the person is exposed to the dangerous pathogen in the future, their immune system will be able to respond immediately, protecting against disease.
How Many Doses Are Administered Daily
Daily number of doses administered per 100 people
The following chart shows the daily number of doses administered per 100 people. This is shown as the rolling seven-day average. Note that this is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime .
Recommended Reading: Can Vaccinated People Get Sick
Which Vaccines Have Been Approved So Far
Health Canada announced the approval of the Pfizer-BioNTech COVID-19 vaccine on Dec. 9, 2020. On Dec. 23, it approved a second vaccine, from Moderna.
On Feb. 26, 2021, Health Canada approved the AstraZeneca-Oxford COVID-19 vaccine.
On March 5, 2021, Johnson & Johnson’s COVID-19 vaccine became the first single-dose vaccine approved for use in Canada.
Health Canada on May 5, 2021. The Pfizer-BioNTech vaccine was then approved for children ages five to 11 on Nov. 19, 2021.
Notes:
May 20: The Canada map was updated to show first and second dose numbers for the provinces and territories. Quebec’s second dose vaccine numbers were added. The chart on vaccine doses distributed now also includes the percentage of doses used and the story text was updated to include additional information on Canada’s vaccine rollout.
Is There Enough Vaccine
Currently, the Pfizer-BioNTech, Oxford-AstraZeneca, Moderna, Novavax and one-shot Janssen vaccines are approved for use throughout the UK.
Others, such that produced by CureVac, have not yet been given the green light.
The UK had ordered more than 540 million doses of seven of the most promising vaccines, including the four so far approved for use.
In addition, the government has now signed deals to buy 114 million more doses of the Pfizer and Moderna vaccines to use in 2022 and 2023.
French vaccine maker Valneva said the UK government had scrapped a deal for 100m doses of its vaccine, which is yet to be approved.
Recommended Reading: Where Can I Get My Kitten Vaccinated For Free
How Is Each State Doing
Some jurisdictions have reached a larger share of their population with vaccines and boosters than others.
*Includes doses provided to Palau, Micronesia and the Marshall Islands.
There are many reasons eligible people are not vaccinated or boosted. Surveys have indicated that some people are adamant in their refusal of the coronavirus vaccines, while others are open to getting a shot but have been putting it off or want to wait and see before making a decision for themselves or for their children.
The first group, surveys have shown, tends to be disproportionately white, rural, evangelical Christian and Republican. The second group tends to be a more diverse and urban group, including many younger people, Black and Latino residents, and Democrats.
Vaccinated People Are Those Most At Risk
The most obvious reason to avoid comparing the vaccinated and unvaccinated death rates are the types of people in each group.
Every state has prioritized people most at risk, so the group of people vaccinated is heavily skewed toward those whose age and medical history make them prone to serious cases of COVID-19, and death from it. So when the expected breakthrough cases do occur, it’s not surprising some deaths would result.
Let’s look at age, for example.
Older adults are at the greatest risk of developing severe illness, requiring hospitalization and dying, with 8 out of 10 COVID-19 deaths reported occurring among adults aged 65 years and up, according to the CDC. And 37% of people vaccinated to date are in that age bracket, even though people 65 and older are just 16% of the total population.
So those vaccinated are a pool of people predisposed to more severe cases.
Among the over 7,000 breakthrough infections reported, nearly 46% are associated with people over the age of 60. We don’t know the ages of those who have died after breakthrough infections because the CDC hasn’t released that data.
Recommended Reading: Does United Healthcare Cover Shingles Vaccine
Are The Most Vulnerable Counties Being Vaccinated
Speed hasnt been the only priority for the countrys vaccination campaign. The Biden administration has also committed to distributing shots equitably to the communities most affected by the pandemic.
More than a year into the rollout, the most socially vulnerable counties in the U.S. have a lower vaccination rate on average than the nations least vulnerable. A majority of the most disadvantaged counties with the fewest fully vaccinated people are in the South, while the most vaccinated, least vulnerable counties are in the Midwest and the Northeast.
Can We Do Better Than Canada Day
Lets look at Manitoba and its webpage loaded with specific vaccination goals, including plans to immunize 122,000 residents in the next 28 daysalong with that aforementioned target to have the capacity to administer 20,000 doses a day by April 1.
With an overall population of 1.4 million, Manitoba has roughly 3.7 per cent of Canadas population of 38 million. If the country as a whole matchesManitobas targeted pace, we will bevaccinating 540,540 Canadians a day.
Manitobas share of those 29.5 million adults waiting for COVID-19 shots is roughly 1.1 million
At its ideal 20,000 shots-per-day rate, Manitoba would take 55 days to give first doses to all remaining adults in the province. If the rest of the country were proceeding at the same pace, it would take the same number of days to inoculate all eligible Canadians. That may sound really ambitious, but on March 10, the Manitoba government reported it already has the capacity to vaccinate 19,000 a day.
So, when is 55 days from today? May 5.
Or, to be conservative, you could start the clock on April 1. In that scenario, every adult gets at least one dose by May 26.
Oh, and guess whats two days beforeMay 26? Victoria Day. If Canada knuckles down and works fast, that long weekend could mark the start of a very, very good summer.
Recommended Reading: How Many People In Oregon Have Been Vaccinated
Who Is Getting Breakthrough Covid Cases
According to the CDC, most of the severe breakthrough cases about 74% had been among seniors who were 65 years or older, CNN reports.
- About 20% of the people who died from COVID-19 after a breakthrough case died from something other than COVID-19, though they had a breakthrough case when they died, according to CNN.
Why The Slow Start
The US health system is complex, with a variety of services run by different providers within each state. These sometimes report to state or local officials but they can also operate independently.
This makes co-ordination challenging when trying to get supplies to local vaccination centres.
Dr Fauci, the president’s top medical adviser, has said: “Whenever you take an undertaking of a magnitude of trying to vaccinate essentially most of the country, there’s always going to be a bump in the road or a hiccup that we see.”
There have also been distribution issues, such as in New York where officials have appealed for more supplies. Governors and mayors in other states have also complained of vaccine shortages.
President Biden’s Chief of Staff, Ron Klain has said a plan to distribute vaccines “out into the community as a whole, did not really exist when we came into the White House”.
Experts say significant logistical problems have arisen as well in administering the vaccines once they have been delivered to states.
As of 20 January, more than 35 million vaccines had been distributed across the US, but less than half of these had been put into people’s arms.
Public health professor at George Washington University, Dr Leana Wen said: “The federal government seemed to have ceded its responsibility at the point the vaccines were given to the states.
Local authorities have said this delay affected the setting up vaccine centres, and hiring staff to work in them.
Recommended Reading: What Are The Vaccines For Babies
Do People Die From Covid After Getting The Covid
New data from the Centers for Disease Control and Prevention suggests 99.999% of people who were fully vaccinated against COVID-19 did not have a severe breakthrough case that led to hospitalization or death, CNN reports.
- Per the CDC, more than 166 million people have been fully vaccinated against COVID-19.
- The new data suggests 1,507 people of those fully vaccinated people died from COVID-19.
- Meanwhile, 7,101 people of those fully vaccinated people were hospitalized from COVID-19.
Covid Vaccine: How Many People Are Vaccinated In The Uk
BBC News
The UK’s Covid vaccine campaign has shifted its focus to boosters – an attempt to reduce the impact of the Omicron variant.
Almost seven in 10 of those aged 12 or over in the UK have had a booster, while nine in 10 have had a single jab and more than eight in 10 have had a second dose.
But despite more than 38 million boosters, or third doses, being given so far, more people are being urged to come forward and jabs are being rolled out to all five to 11-year-olds.
Don’t Miss: How Long Does It Take To Make A New Vaccine
Details About The Data
Doses administered: Total vaccine doses administered to individuals. This is not a measure of fully vaccinated individuals.
First dose: People who have received the first dose of a COVID-19 vaccine series from Pfizer or Moderna.
Final dose: These are fully vaccinated individuals, who have either received the second dose of the Pfizer or Moderna vaccine, or one dose of the Johnson & Johnson vaccine.
Population first dose %: First doses completed, divided by the Census population count.
Population final dose %: The percentage of fully vaccinated individuals in the population.
Census Population: Based on 2019 Census data. Includes all Maine residents, though COVID-19 vaccine is currently authorized only for people age 5 and older. None of the vaccines are currently authorized for persons under age 5.
Booster/Additional: This includes all doses a patient has received beyond the initial series . These include booster doses and additional doses for immune compromised individuals. This will also contain the second dose of any three dose series.
Details Of Vaccination Data
This spreadsheet is based on the information made available at the time of publishing and may be subject to changes. Please take note of any notes and caveats on each sheet.
The below attachments provide some analysis on our progress on equity. The two PDF files are high level summaries of overall progress. The Excel documents are interactive and provides the ability to delve further into those overall numbers. NB: These Excel workbooks use features that are non-compatible with versions of MS Office 2016 and earlier.
Also Check: Does Cvs Have Meningitis Vaccine
Adverse Events Following Immunisations
Like all medicines, the COVID-19 vaccine may cause side effects in some people. These are common, are usually mild, dont last long and wont stop people from having the second dose or going about daily life. Serious allergic reactions do occur but are extremely rare.
Suspected AEFI to COVID-19 vaccines are reported to the Centre for Adverse Reactions Monitoring . Medsafe is closely monitoring the AEFI reported from the use of the COVID-19 vaccine and will report regularly on their findings.
Adults Ages 18 Years And Older
Primary Series:2 doses of Moderna given 4-8 weeks apart
Fully Vaccinated AND Up to Date: 2 weeks after final dose in primary series, since a booster is not currently recommended for children in this age group who have received the Moderna primary series
1 Talk to your healthcare or vaccine provider about the timing for the 2nd dose in your primary series.
- People ages 6 months through 64 years, and especially males ages 12 through 39 years, may consider getting the 2nd primary dose of an mRNA COVID-19 vaccine 8 weeks after the 1st dose. A longer time between the 1st and 2nd primary doses may increase how much protection the vaccines offer, and further minimize the rare risk of heart problems, including myocarditis and pericarditis.
- People ages 65 years and older, people more likely to get very sick from COVID-19, or anyone wanting protection due to high levels of community transmission should get:
- the second dose of Pfizer-BioNTech COVID-19 vaccine 3 weeks after the first dose, or
- the second dose of Moderna COVID-19 vaccine 4 weeks after the first dose.
- People ages 18 years and older should get their second dose of Novavax 3-8 weeks after the first dose.
- People ages 18 years and older who are moderately or severely immunocompromised should get the second dose of Novavax 3 weeks after the first dose.
2 If you have completed your primary seriesbut are not yet eligible for a boosteryou are also considered up to date.
Also Check: What Age Is Meningitis B Vaccine Given